Novartis' Q3 Attributable Net Income Falls; Net Sales Rise

02:20 AM EDT, 10/27/2026 (MT Newswires) -- Novartis (NOVN.SW) logged $1.20 billion in net income attributable to shareholders for the third quarter, compared with $3.93 billion a year ago. EPS moved to $0.63 from $2.02 year over year, a Tuesday filing showed. For the three months ended Sept. 30, net sales to third parties were $14.52 billion versus $13.91 billion previously, the Swiss pharmaceutical giant added. Looking ahead, the group expects low-single-digit year-over-year growth in net sales for full-year 2026.